BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+46.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
+$7.07B
(+37%)
Cap. Flow
+$60.6M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
231
New
17
Increased
84
Reduced
52
Closed
23
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$38.5M |
| 2 |
Generation Bio
GBIO
|
$30.2M |
| 3 |
Stryker
SYK
|
$27.2M |
| 4 |
Insulet
PODD
|
$25.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
$23.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.3M |
| 2 |
Moderna
MRNA
|
$38.9M |
| 3 |
Illumina
ILMN
|
$38.1M |
| 4 |
Intuitive Surgical
ISRG
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$31.2M |
Sector Composition
| 1 | Healthcare | 96.05% |
| 2 | Industrials | 0.58% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.29% |
| 5 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
101
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $10.9M | 0.15% |
58,000
-500
| -0.9% | -$94.2K |
|
102
iRhythm Technologies
IRTC
$5.46B
| $10.8M | 0.15% |
93,140
-40,119
| -30% | -$4.65M |
|
103
Phreesia
PHR
$1.88B
| $10.7M | 0.15% |
377,169
+16,171
| +4% | +$457K |
|
104
Cidara Therapeutics
CDTX
$1.66B
| $10.4M | 0.15% |
2,822,495
| – | – |
|
105
Gilead Sciences
GILD
$140B
| $10.3M | 0.15% |
134,500
-10,000
| -7% | -$769K |
|
|
SILK
106
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $10.3M | 0.15% |
245,338
+50,755
| +26% | +$2.13M |
|
107
Guardant Health
GH
$8.41B
| $10.3M | 0.15% |
126,561
+21,267
| +20% | +$1.73M |
|
108
Health Catalyst
HCAT
$239M
| $10.2M | 0.14% |
349,169
+96,169
| +38% | +$2.81M |
|
109
BioMarin Pharmaceuticals
BMRN
$11.2B
| $9.49M | 0.13% |
76,900
+4,800
| +7% | +$592K |
|
110
Integra LifeSciences
IART
$1.18B
| $9.44M | 0.13% |
200,897
+3,477
| +2% | +$163K |
|
|
SGEN
111
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.33M | 0.13% |
54,900
+13,500
| +33% | +$2.29M |
|
112
Labcorp
LH
$23.1B
| $9.01M | 0.13% |
54,234
+36,373
| +204% | +$6.04M |
|
|
OXFD
113
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $8.89M | 0.13% |
683,795
+21,480
| +3% | +$279K |
|
|
HZNP
114
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.79M | 0.12% |
158,200
-7,800
| -5% | -$434K |
|
|
XENT
115
DELISTED
Intersect ENT, Inc
XENT
| $7.62M | 0.11% |
563,090
+18,068
| +3% | +$245K |
|
116
Transmedics
TMDX
$3.92B
| $7.62M | 0.11% |
+425,000
| New | +$7.62M |
|
|
VCRA
117
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $7.3M | 0.1% |
344,081
-6,643
| -2% | -$141K |
|
118
Cooper Companies
COO
$13.4B
| $7.19M | 0.1% |
25,345
| – | – |
|
119
Dentsply Sirona
XRAY
$2.85B
| $7.01M | 0.1% |
159,129
+31,091
| +24% | +$1.37M |
|
120
Quest Diagnostics
DGX
$20.3B
| $6.84M | 0.1% |
+60,005
| New | +$6.84M |
|
121
Avantor
AVTR
$9.18B
| $6.2M | 0.09% |
364,877
+50,311
| +16% | +$855K |
|
122
Legend Biotech
LEGN
$6.41B
| $5.71M | 0.08% |
+134,261
| New | +$5.71M |
|
123
Inogen
INGN
$216M
| $5.29M | 0.07% |
148,912
+25,517
| +21% | +$906K |
|
|
QTNT
124
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $4.43M | 0.06% |
599,154
+243,255
| +68% | +$1.8M |
|
|
NUVA
125
DELISTED
NuVasive, Inc.
NUVA
| $3.7M | 0.05% |
+66,500
| New | +$3.7M |
|